Strs Ohio Grows Stock Position in Align Technology, Inc. $ALGN

Strs Ohio increased its holdings in shares of Align Technology, Inc. (NASDAQ:ALGN) by 32.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 6,638 shares of the medical equipment provider’s stock after buying an additional 1,638 shares during the quarter. Strs Ohio’s holdings in Align Technology were worth $1,257,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in ALGN. Cromwell Holdings LLC lifted its position in Align Technology by 2,900.0% during the second quarter. Cromwell Holdings LLC now owns 180 shares of the medical equipment provider’s stock worth $34,000 after buying an additional 174 shares during the period. SVB Wealth LLC purchased a new position in Align Technology during the first quarter worth about $36,000. Farther Finance Advisors LLC lifted its position in Align Technology by 42.2% during the second quarter. Farther Finance Advisors LLC now owns 310 shares of the medical equipment provider’s stock worth $59,000 after buying an additional 92 shares during the period. Covestor Ltd lifted its position in Align Technology by 18.8% during the first quarter. Covestor Ltd now owns 493 shares of the medical equipment provider’s stock worth $78,000 after buying an additional 78 shares during the period. Finally, Assetmark Inc. lifted its position in Align Technology by 327.6% during the second quarter. Assetmark Inc. now owns 449 shares of the medical equipment provider’s stock worth $85,000 after buying an additional 344 shares during the period. 88.43% of the stock is currently owned by hedge funds and other institutional investors.

Align Technology Stock Performance

ALGN stock opened at $137.21 on Thursday. Align Technology, Inc. has a 1 year low of $122.00 and a 1 year high of $246.19. The firm has a market cap of $9.95 billion, a P/E ratio of 26.59, a price-to-earnings-growth ratio of 1.49 and a beta of 1.70. The stock has a 50-day simple moving average of $132.89 and a 200-day simple moving average of $161.10.

Align Technology (NASDAQ:ALGN) last posted its earnings results on Wednesday, October 29th. The medical equipment provider reported $2.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.38 by $0.23. Align Technology had a return on equity of 14.06% and a net margin of 9.50%.The business had revenue of $995.69 million during the quarter, compared to analyst estimates of $980.75 million. During the same quarter last year, the firm earned $2.35 earnings per share. The company’s revenue for the quarter was up 1.8% compared to the same quarter last year. Align Technology has set its Q4 2025 guidance at EPS. On average, equities research analysts predict that Align Technology, Inc. will post 7.98 EPS for the current year.

Align Technology announced that its Board of Directors has authorized a share repurchase plan on Tuesday, August 5th that allows the company to buyback $200.00 million in shares. This buyback authorization allows the medical equipment provider to reacquire up to 2% of its stock through open market purchases. Stock buyback plans are often an indication that the company’s leadership believes its shares are undervalued.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on ALGN. Needham & Company LLC reiterated a “hold” rating on shares of Align Technology in a research report on Thursday, October 30th. Leerink Partners increased their target price on Align Technology from $172.00 to $189.00 in a research report on Thursday, October 30th. Mizuho dropped their price target on Align Technology from $210.00 to $170.00 and set an “outperform” rating for the company in a research note on Monday, October 13th. Morgan Stanley upped their price target on Align Technology from $142.00 to $154.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 30th. Finally, Zacks Research upgraded Align Technology from a “strong sell” rating to a “hold” rating in a research note on Tuesday, September 30th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, seven have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $175.45.

About Align Technology

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.